Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Akelos
AddedFeb 16, 2024
UpdatedJun 18, 2026
Akelos

Akelos

Seed

Akelos, a NY-based biopharmaceutical company, develops innovative non-opioid drugs for neuropathic pain treatment.

HQ
New York City, NY, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Akelos, a New York-based biopharmaceutical company, was founded to address the opioid epidemic by developing innovative non-opioid drugs for the treatment of neuropathic pain. The company's core mission is to translate cutting-edge scientific research into effective treatments for chronic and neuropathic pain, aiming to provide safer alternatives to opioids. Akelos is currently focused on advancing two drug candidates in pre-clinical development, with a strong emphasis on non-narcotic solutions.

Notable affiliates include Dr. Steven Fox, who plays a pivotal role in the company's research and development efforts. Akelos has established a significant research collaboration to develop and commercialize a novel non-opioid anti-hyperalgesic drug. This partnership underscores the company's commitment to addressing unmet medical needs. Akelos has made substantial strides in the biopharmaceutical industry, contributing to the broader effort to mitigate the opioid crisis through innovative pain management solutions.

Akelos - Similar Companies

Aiko Biotechnology logo

Aiko Biotechnology

Concentric Analgesics logo

Concentric Analgesics

Latigo Biotherapeutics logo

Latigo Biotherapeutics

latigobio.com

Alkeus Pharmaceuticals logo

Alkeus Pharmaceuticals

alkeus.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Xdynia logo

Xdynia

Isosceles Pharmaceuticals logo

Isosceles Pharmaceuticals

Neurocarrus logo

Neurocarrus

neurocarrus.com

Axsome Therapeutics logo

Axsome Therapeutics

axsome.com

Acelot logo

Acelot

acelot.com

Essential Remedium logo

Essential Remedium

Accuitis logo

Accuitis

accuitis.com

PleoPharma logo

PleoPharma

pleopharma.com

Sollis Therapeutics logo

Sollis Therapeutics

Acesis BioMed logo

Acesis BioMed

acesisbio.com

Akelos - Quick Facts

Who are Akelos' competitors?

Companies similar to Akelos include Aiko Biotechnology, Concentric Analgesics, Latigo Biotherapeutics and Alkeus Pharmaceuticals.

When was Akelos founded?

Akelos was founded in 2018.

Where is Akelos' headquarters located?

Akelos' headquarters is located in New York City, NY, US.

When was Akelos' last funding round?

Akelos' most recent funding round was for $1.8M (USD) in January 2020.

How much has Akelos raised to-date?

As of Jan 22, 2020, Akelos has raised a total of $2.1M (USD).

How many employees does Akelos have?

Akelos has 5 employees as of Feb 5, 2024.

Akelos - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified